Harrow (HROW) Asset Writedowns and Impairment (2016 - 2026)
Harrow (HROW) posted quarterly Asset Writedowns and Impairment of -$195000.0 for Q1 2026, down 271.05% year-over-year from $114000.0 in Q1 2025, and down 143.75% quarter-over-quarter from -$80000.0 in Q4 2025.
Harrow (HROW) Asset Writedowns and Impairment (2016 - 2026) Analysis & Trends
Harrow's Asset Writedowns and Impairment history runs 8 years deep, the most recent figure standing at -$195000.0 for Q1 2026.
- In Q1 2026, Asset Writedowns and Impairment fell 271.05% year-over-year to -$195000.0; the TTM figure through Mar 2026 stood at $159000.0 (down 50.16% YoY), while the FY2025 annual figure was $468000.0, up 290.0% from the prior year.
- Asset Writedowns and Impairment for Q1 2026 stood at -$195000.0, down from -$80000.0 in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $264000.0 in Q4 2023, with the low at -$195000.0 in Q1 2026.
- The 5-year median for Asset Writedowns and Impairment is $20000.0 (2023), against an average of $47411.8.
- The sharpest annual moves came in 2022 and 2024: Asset Writedowns and Impairment surged 4600.0% in 2022, then sank 525.0% in 2024.
- Harrow's Asset Writedowns and Impairment stood at $45000.0 in 2022, then surged by 486.67% to $264000.0 in 2023, then plunged by 46.97% to $140000.0 in 2024, then slumped by 157.14% to -$80000.0 in 2025, then tumbled by 143.75% to -$195000.0 in 2026.
- Business Quant data shows HROW's Asset Writedowns and Impairment at -$195000.0 in Q1 2026, -$80000.0 in Q4 2025, and $208000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Harrow | 1.53 Bn | 1.45 Bn | 50.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -100,000.00 |
| Jun 30, 2026 | -100,000.00 |
| Mar 31, 2026 | -195,000.00 |
| Mar 31, 2026 | -195,000.00 |
| Dec 31, 2025 | -80,000.00 |
| Dec 31, 2025 | -80,000.00 |
| Sep 30, 2025 | 208,000.00 |
| Sep 30, 2025 | 208,000.00 |
| Jun 30, 2025 | 226,000.00 |
| Jun 30, 2025 | 226,000.00 |
| Mar 31, 2025 | 114,000.00 |
| Mar 31, 2025 | 114,000.00 |
| Dec 31, 2024 | 140,000.00 |
| Dec 31, 2024 | 140,000.00 |
| Sep 30, 2024 | 76,000.00 |
| Sep 30, 2024 | 76,000.00 |
| Jun 30, 2024 | -11,000.00 |
| Jun 30, 2024 | -11,000.00 |
| Mar 31, 2024 | -85,000.00 |
| Mar 31, 2024 | -85,000.00 |